共 50 条
- [2] Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine Experimental Hematology & Oncology, 10
- [8] Brentuximab vedotin — a new standard for cutaneous T-cell lymphoma Nature Reviews Clinical Oncology, 2017, 14 : 460 - 460